[The EEG background activity in children with epilepsy--effects of the removal of anticonvulsants on the EEG]. 1993

K Hongou, and T Konishi, and Y Naganuma, and M Murakami, and M Yamatani, and T Okada
Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University.

The development of the EEG background activity is generally impaired in children with epilepsy. Antiepileptic drugs (AEDs) are one of the important factor which influence the EEG background activity. We studied the effect of AEDs on the EEG. Subjects were 46 normal children and 48 children with epilepsy aged 5 to 15, who had not any organic brain damage and showed normal psychomotor development. Forty children with epilepsy (CBZ; 30 cases, VPA; 10 cases) had been on monopharmacy and 8 cases on polypharmacy. All of them have outgrown their epilepsy. The serial EEGs were recorded during withdrawal and after discontinuation of AED in each patient. These records were evaluated using computerized power spectral analysis. CBZ reduction associated with a decrease in delta and theta powers and an increase in alpha-2 power, which were also observed at VPA reduction in concomitant AEDs (VPA+CBZ). No parameter changed by VPA reduction in monopharmacy. The slowing of the EEG background activity was noticed even after discontinuation of CBZ. It required more time after discontinuation of CBZ in younger children than older before the EEG background activity became normal controls. These findings suggested that CBZ had a adverse effect, which was more remarkable in younger children than older children, on the development of EEG background activity and that the effect of CBZ on EEG was different from that of VPA.

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic

Related Publications

K Hongou, and T Konishi, and Y Naganuma, and M Murakami, and M Yamatani, and T Okada
June 1990, The Japanese journal of psychiatry and neurology,
K Hongou, and T Konishi, and Y Naganuma, and M Murakami, and M Yamatani, and T Okada
January 1987, Cephalalgia : an international journal of headache,
K Hongou, and T Konishi, and Y Naganuma, and M Murakami, and M Yamatani, and T Okada
June 2013, Journal of epilepsy research,
K Hongou, and T Konishi, and Y Naganuma, and M Murakami, and M Yamatani, and T Okada
July 2008, Seizure,
K Hongou, and T Konishi, and Y Naganuma, and M Murakami, and M Yamatani, and T Okada
December 1996, Drug safety,
K Hongou, and T Konishi, and Y Naganuma, and M Murakami, and M Yamatani, and T Okada
January 1992, Epilepsy research. Supplement,
K Hongou, and T Konishi, and Y Naganuma, and M Murakami, and M Yamatani, and T Okada
May 1993, The International journal of neuroscience,
K Hongou, and T Konishi, and Y Naganuma, and M Murakami, and M Yamatani, and T Okada
January 1975, Roczniki Akademii Medycznej im. Juliana Marchlewskiego w Bialymstoku,
K Hongou, and T Konishi, and Y Naganuma, and M Murakami, and M Yamatani, and T Okada
January 1977, Neuropsychologia,
K Hongou, and T Konishi, and Y Naganuma, and M Murakami, and M Yamatani, and T Okada
November 1999, Epilepsia,
Copied contents to your clipboard!